Section Arrow
Quote
ICCM.NASDAQ
- IceCure Medical Ltd
(Financial Status)
Quotes are at least 15-min delayed:2026/03/09 19:28 EDT
After Hours
Last
 0.611
-0.0019 (-0.31%)
Bid
0.611
Ask
0.6415
High 0.6129 
Low 0.61 
Volume 974 
Regular Hours (Closed)
Last
 0.6129
-0.0276 (-4.31%)
Day High 
0.628 
Prev. Close
0.6405 
1-M High
0.67 
Volume 
1.31M 
Bid
0.611
Ask
0.6415
Day Low
0.5951 
Open
0.596 
1-M Low
0.56 
Market Cap 
43.45M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.61 
20-SMA 0.6 
50-SMA 0.63 
52-W High 1.429271 
52-W Low 0.5401 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.25/-0.21
Enterprise Value
43.61M
Balance Sheet
Book Value Per Share
0.13
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.29M
Operating Revenue Per Share
0.05
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.65+3.09+2.82%29.21PE
After Hours 112.4 -0.25 -0.22%
BSXBoston Scientific Corp71.9+0.55+0.77%36.78PE
After Hours 71.9 0 0.00%
MDTMedtronic plc91.34+0.44+0.48%25.39PE
After Hours 91.25 -0.09 -0.10%
BFLYButterfly Network3.76+0.11+3.01%-- 
After Hours 3.7 -0.06 -1.60%
PACBPacific Biosciences of California1.39+0.01+0.72%-- 
After Hours 1.3997 +0.0097 +0.70%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.